Marker Therapeutics was awarded a $2 million grant from NIH Small Business Innovation Research Program (SBIR) to support the clinical investigation of MT-601 in patients with lymphoma who have ...

At this year’s Fall convocation ceremonies on Nov. 20 and 21, the university will honour the achievements of artist, poet and ...

Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

The vaccine appears to be safe and effective against triple-negative breast cancer -- a type that can’t be treated with ...

Chronic fatigue and long Covid remain poorly understood, but Dr Perrin’s unusual techniques are having surprisingly positive ...

The hope is that patients who are given the personalised vaccines have a better chance of long-term survival and cure' ...

A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The ...

WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- The blockbuster GLP-1 drug semaglutide ( Ozempic, Wegovy) could curb drinking ...

The funding will make the hospital's new MRI truly state-of-the-art by adding new imaging methods, allowing users to see more ...

While not powered for statistical efficacy, the study showed promising trends favoring topical pravibismane plus standard of care (SoC) evaluating exploratory efficacy endpoints including complete ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr.